InvestWiser

Ambu A/S

AMBU-BNasdaq CopenhagenHealthcareMarket value 20.2 bn DKK
89.20DKK −2.1%
last day · Price as of 18 November 2026

The answer first

Does Ambu beat the market?

No, Ambu has not beaten the market over the last year.

Ambu+5.9%København (OMXCGI)+15.7%
  • The ranking · Quality, value and trend combined

    Better than 71% of Nordic stocks

    • Quality82
    • Value23
    • Trend79

    No. 36 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Ambu keeps must grow about 14% a year for 10 years.

Max for seven days

Follow Ambu with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Ambu

From today, at a price of 89.20 DKK. Write why you follow Ambu, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Ambu

Your first answer is free, no account needed.

Do you own Ambu, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Ambu and a few more. Free, no card.

Past year against the exchange and Super Stock
Ambu+5.9%København (OMXCGI)+15.7%Super Stock+45.9%
14 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Ambu has risen 5.9% over the past year, including dividends.
  • Overall, Ambu ranks better than 71% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 78.0%. The price is 74.6% below its peak now.

Who owns Ambu? See the major shareholders and their stakes

What do analysts think of Ambu?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

71

Quality, value and trend together. Better than 71% of Nordic stocks.

No. 36 of 195 in healthcare

Quality82
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 46 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.11
  • Asset turnoverSales divided by everything the company owns0.79
  • Return on equityProfit divided by equity+10.3%
  • Cash conversionOperating cash flow divided by profit1.66

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value23
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 90 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity3.6
  • P/SPrice divided by sales3.5
  • P/EPrice divided by earnings35.4
  • P/CFPrice divided by operating cash flow21.4

The ranking is built on P/E, P/B and P/S.

Trend79
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 40 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+18.2%
  • 6 months+32.3%
  • 9 months+9.3%
  • 12 months+5.9%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+16.0%
3 years, per year
+8.0%
5 years, per year
−12.1%
10 years, per year
+2.0%
Largest fall, 3 years
−78.0%
From a peak to the bottom
From the peak now
−74.6%
How far the price is from the peak
Volatility, 1 year
35.4%
How much the price swings over a year
Beta, 1 year
0.76
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Ambu

17 funds we follow own Ambu. The share is how much of the fund the stock makes up.

  • Norway3
  • Sweden7
  • Denmark7
  • 1 ETF

From the funds' latest known holdings.

About Ambu

Ambu A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 4,700 employees.

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes.

See the full analysis of Ambu.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Copenhagen

Explore the stock market